GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
SANTA MONICA, Calif., December 05, 2024 BUSINESS WIRE GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look at fill trends and spending patterns for weight loss medications across the U.S. The company found that limited insurance coverage and high out-of-pocket costs aren't slowing down interest in popular drugs used for weight loss such as Mounjaro, Ozempic, Wegovy, and Zepbound. In fact, some of these popular drugs have seen fills more than double in just the past year. What's more, GoodRx's research shows that Americans overspent by at least $200 million in 2024 by paying the full retail price for their weight loss medications and not leveraging savings available on GoodRx, showcasing an astounding willingness to access these medications at any cost. Highlights from the new research include: Surging fill rates: Even as patients grapple with high costs and limited insurance
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Prof G's mother being ‘underinsured' fueled him to get rich — says America ‘focuses on shareholders' over wellbeing [Yahoo! Finance]Yahoo! Finance
- GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Seven Reasons Regular Health Checkups With Your Doctor Save You Money [Forbes]Forbes
- GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Morgan Stanley from $7.00 to $6.00. They now have an "equal weight" rating on the stock.MarketBeat
- GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. CountiesBusiness Wire
GDRX
Earnings
- 11/7/24 - Beat
GDRX
Sec Filings
- 12/23/24 - Form 4
- 12/18/24 - Form SCHEDULE
- 12/18/24 - Form SCHEDULE
- GDRX's page on the SEC website